FDA Announces Grant Funding for HLA-Associated Influenza Vaccine Development

Summary

The FDA is seeking a collaboration with the University of Oklahoma Health Sciences Center to develop technology to identify and characterize influenza peptides presented on human cells, with the goal of creating universal vaccines for long-lasting immunity.